Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Laure Sellier-Leclerc

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Seminars in Thrombosis and Hemostasis|September 25, 2010
Plasmatherapy in atypical hemolytic uremic syndromeChantal Loirat, Arnaud Garnier, Anne-Laure Sellier-Leclerc, et al.
Nephrologie & Therapeutique|April 29, 2021
[Interferent RNA treatment: Example of primary hyperoxaluria]Pierre Cochat, Anne-Laure Sellier-Leclerc, Aurélia Bertholet-Thomas, et al.
Pediatric Nephrology (Berlin, Germany)|June 4, 2011
Acute tubulointerstitial nephritisTim Ulinski, Anne-Laure Sellier-Leclerc, Elena Tudorache, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2026
Don't think that combined liver kidney transplant can solve everything in primary hyperoxaluria type 1!Sandrine Lemoine, Anne-Laure Sellier-Leclerc, Alice Koenig, et al.
Pediatric Nephrology (Berlin, Germany)|March 28, 2021
Pediatric atypical hemolytic-uremic syndrome due to auto-antibodies against factor H: is there an interest to combine eculizumab and mycophenolate mofetil?Lucie Matrat, Justine Bacchetta, Bruno Ranchin, et al.
Pediatric Nephrology (Berlin, Germany)|May 24, 2013
Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndromeAnne-Laure Sellier-Leclerc, Emre Belli, Valérie Guérin, et al.
Pediatric Transplantation|June 3, 2022
Rituximab as induction therapy in pediatric kidney transplantation: A single-center experience in four patientsJosselin Bernard, Anne-Laure Sellier-Leclerc, Delphine Demède, et al.
Pediatric Nephrology (Berlin, Germany)|February 26, 2017
C3 glomerulopathy and eculizumab: a report on four paediatric casesCélia Lebreton, Justine Bacchetta, Frédérique Dijoud, et al.
The New England Journal of Medicine|March 13, 2024
Lumasiran, Isolated Kidney Transplantation, and Continued VigilanceJustine Bacchetta, Stéphanie Clavé, Peggy Perrin, et al.
Pediatric Nephrology (Berlin, Germany)|August 24, 2014
Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiencyKatell Michaux, Justine Bacchetta, Etienne Javouhey, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Seminars in Thrombosis and Hemostasis|September 25, 2010
Plasmatherapy in atypical hemolytic uremic syndromeChantal Loirat, Arnaud Garnier, Anne-Laure Sellier-Leclerc, et al.
Nephrologie & Therapeutique|April 29, 2021
[Interferent RNA treatment: Example of primary hyperoxaluria]Pierre Cochat, Anne-Laure Sellier-Leclerc, Aurélia Bertholet-Thomas, et al.
Pediatric Nephrology (Berlin, Germany)|June 4, 2011
Acute tubulointerstitial nephritisTim Ulinski, Anne-Laure Sellier-Leclerc, Elena Tudorache, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2026
Don't think that combined liver kidney transplant can solve everything in primary hyperoxaluria type 1!Sandrine Lemoine, Anne-Laure Sellier-Leclerc, Alice Koenig, et al.
Pediatric Nephrology (Berlin, Germany)|March 28, 2021
Pediatric atypical hemolytic-uremic syndrome due to auto-antibodies against factor H: is there an interest to combine eculizumab and mycophenolate mofetil?Lucie Matrat, Justine Bacchetta, Bruno Ranchin, et al.
Pediatric Nephrology (Berlin, Germany)|May 24, 2013
Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndromeAnne-Laure Sellier-Leclerc, Emre Belli, Valérie Guérin, et al.
Pediatric Transplantation|June 3, 2022
Rituximab as induction therapy in pediatric kidney transplantation: A single-center experience in four patientsJosselin Bernard, Anne-Laure Sellier-Leclerc, Delphine Demède, et al.
Pediatric Nephrology (Berlin, Germany)|February 26, 2017
C3 glomerulopathy and eculizumab: a report on four paediatric casesCélia Lebreton, Justine Bacchetta, Frédérique Dijoud, et al.
The New England Journal of Medicine|March 13, 2024
Lumasiran, Isolated Kidney Transplantation, and Continued VigilanceJustine Bacchetta, Stéphanie Clavé, Peggy Perrin, et al.
Pediatric Nephrology (Berlin, Germany)|August 24, 2014
Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiencyKatell Michaux, Justine Bacchetta, Etienne Javouhey, et al.
Pageof 9